microRNA-145

Basic Information

Uniprot ID:
Secondary ID:
Symbol: miR-145
Other Name:
Class: Epigenetics
Type: pro/anti-fibrotic
Molecular Function:

Target Classification

Category I Category II Category III
Intracellular Epigenetics microRNA

Related Compound

Fibrosis Related Property

Reference Record 1

PubMed ID 28091538 Compound ID
CAS Name
Model vitro,human Fibrosis Disease Liver fibrosis
Process I
Process II HSC activation
Process III
Mechanism Targeting krüppel-like factor 4

Reference Record 2

PubMed ID 27922673 Compound ID
CAS Name
Model vitro,human Fibrosis Disease Chondrocyte fibrosis
Process I
Process II
Process III prevenet collagen deposition
Mechanism Targeting TNFRSF11B

Reference Record 3

PubMed ID 26165705 Compound ID
CAS Name
Model vitro,human Fibrosis Disease Corneal fibrosis
Process I
Process II fibroblasts differetiation,fibroblasts migration
Process III
Mechanism

Reference Record 4

PubMed ID 27289031 Compound ID
CAS Name
Model Fibrosis Disease Liver fibrosis
Process I
Process II
Process III
Mechanism

Reference Record 5

PubMed ID 25876136 Compound ID
CAS Name
Model vitro,human Fibrosis Disease Scar
Process I
Process II myofibroblasts migration
Process III
Mechanism

Reference Record 6

PubMed ID 25323858 Compound ID
CAS Name
Model vitro,mice Fibrosis Disease Cardiac fibrosis
Process I
Process II
Process III prevenet collagen deposition
Mechanism

Reference Record 7

PubMed ID 23632450 Compound ID
CAS Name
Model human Fibrosis Disease Cystic fibrosis
Process I
Process II
Process III
Mechanism

Reference Record 8

PubMed ID 23457217 Compound ID
CAS Name
Model vitro,human,mice Fibrosis Disease Pulmonary fibrosis
Process I
Process II myofibroblasts differentiation
Process III prevenet collagen deposition
Mechanism

Reference Record 9

PubMed ID 22307526 Compound ID
CAS Name
Model vitro,human Fibrosis Disease Systemic sclerosis
Process I
Process II
Process III
Mechanism

Reference Record 10

PubMed ID 28902846 Compound ID
CAS Name
Model vitro,human Fibrosis Disease Liver fibrosis
Process I
Process II
Process III
Mechanism Targeting ADD3